Clinical Trials Browser

Phase 1 × Camurati-Engelmann Syndrome × Lymphoid × Clear all

NCT06487624 2026-02-05

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

Phase 1 Recruiting

Camurati-Engelmann Syndrome, Hodgkin Disease, Neoplasms